Relay Therapeutics Appoints New Chief Medical Officer
Ticker: RLAY · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1812364
| Field | Detail |
|---|---|
| Company | Relay Therapeutics, Inc. (RLAY) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, cmo
TL;DR
Relay Therapeutics just hired a new CMO, Sarah Michaels, effective June 8th. Big leadership change incoming.
AI Summary
Relay Therapeutics, Inc. announced on June 11, 2025, that its Board of Directors appointed Dr. Sarah Michaels as Chief Medical Officer, effective June 8, 2025. The company also disclosed compensatory arrangements for certain officers and filed financial statements and exhibits.
Why It Matters
The appointment of a new Chief Medical Officer is a key leadership change that could signal strategic shifts in the company's drug development and clinical trial plans.
Risk Assessment
Risk Level: medium — Leadership changes, especially for critical roles like CMO, can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Relay Therapeutics, Inc. (company) — Registrant
- Sarah Michaels (person) — Newly appointed Chief Medical Officer
- June 8, 2025 (date) — Effective date of appointment
- June 11, 2025 (date) — Date of report
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Sarah Michaels has been appointed as the new Chief Medical Officer.
When is the new Chief Medical Officer's appointment effective?
The appointment of Dr. Sarah Michaels is effective as of June 8, 2025.
What other information is included in this 8-K filing?
The filing also includes information on compensatory arrangements for certain officers and financial statements and exhibits.
What is Relay Therapeutics, Inc.'s principal executive office address?
Relay Therapeutics, Inc.'s principal executive office is located at 60 Hampshire Street, Cambridge, Massachusetts 02139.
What is the SIC code for Relay Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Relay Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 by Sarah Michaels regarding Relay Therapeutics, Inc. (RLAY).